Skip to main content
Log in

Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies

  • Published:
Journal of Huazhong University of Science and Technology Aims and scope Submit manuscript

Summary

Multiplex reverse transcription-polymerase chain reaction (M-RT-PCR) has been proved to possess great clinical potential for simultaneous screening of 29 chromosomal translocations in acute leukemia. To evaluate the clinical value of M-RT-PCR in hematologic malignancies, bone marrow samples from 90 patients with various hematologic malignancies, including 25 acute myelogenous leukemia (AML), 22 acute lymphoblastic leukemia (ALL), 27 chronic myelogenous leukemia (CML), 4 myeloproliferative diseases (MPD), 3 chronic lymphoblastic leukemia (CLL), 3 non-Hodgkin’s lymphoma (NHL), 3 myelodysplastic syndrome (MDS), 2 multiple myeloma (MM) and 1 malignant histocytosis (MH) were subjected to both M-RT-PCR and chromosome karyotypic analysis. Some of cases were subjected to follow-up examination of M-RT-PCR during the period of clinical complete remission (CR) for detection of minimal residual leukemia. In our hand, 12 of 29 chromosomal translocation transcripts including TEL/PDGFR, DEK/CAN, MLL/AF6, AML1/ETO, MLL/AF9, BCR/ABL, MLL/MLL, PML/RARα, TLS/ERG, E2A/HLF, EVI1 and HOXI1 were detected in 57 cases (63.3 %) of the 90 samples, which were in consistence with the results of karyotypic analysis. Furthermore, M-RT-PCR had also shown good clinical relevance when used as an approach to detect minimal residual leukemia. We concluded that M-RT-PCR could be used as an efficient and fast diagnostic tool not only in the initial diagnosis of hematologic malignancies but also in subsequent monitor of minimal residual leukemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pallisgaard N, Hokland P, Riishoj D C et al. Multiplex reverse translocation polymerase chain reaction for simultaneous screening of 29 translocation and chromosomal aberrations in acute leukemia. Blood, 1998,92(2):574–588

    PubMed  CAS  Google Scholar 

  2. He J, Xue Y Q, Li J Q et al. A combined assay of multiplex RT-PCR and karyotypic analysis in childhood acute lymphoblastic leukemia. Chin J Hematol, 2004,25(7):413–416

    Google Scholar 

  3. Li Z G, Wu M Y, Zhao W et al. Detection of 29 types of fusion gene in leukemia by multiplex RT-PCR. Chin J Hematol, 2003,24(5):256–258

    Google Scholar 

  4. Ogawa S, Kurokawa M, Tanaka K et al. Increased EVI1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia, 1996,10(5):788–794

    PubMed  CAS  Google Scholar 

  5. Nakamura Y, Nakazato H, Sato Y et al. Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13). Am J Hematol, 2002,69(1):80–82

    Article  PubMed  CAS  Google Scholar 

  6. Soekarman D, von Lindern M, Daenen S et al. The translocation (6;9) (p23;q34) shows consistent rearranagement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood, 1992,79(11):2990–2997

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, M., Li, C., Huang, L. et al. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies. J. Huazhong Univ. Sc. Technol. 26, 661–663 (2006). https://doi.org/10.1007/s11596-006-0608-2

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-006-0608-2

Key words

Navigation